x

Search for a clinical trial

* (*) mandatory field

193 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Ongoing trial
PMNN: Personalized Medicine for Membranous Nephropathy
Faculté de médecine de Nice Sophia-Antipolis
CHU Nice

UNITED KINGDOM

Greater London
LONDON

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCE

BRETAGNE
RENNES

Recruiting trial
Ongoing trial
SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis
CHU de Rennes - Hôpital Pontchaillou
Service de Radiologie et imagerie médicale - Imagerie thoracique et cardio-vasculaire

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
AP-HP.Centre - Université de Paris - Hôpital Cochin
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
ITAC: Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That of Cyclophosphamide in Severe Behçet's Disease.
APHP.Sorbonne Université, Hôpital de la Pitié-Salpętričre
Département de Médecine Interne et Immunologie Clinique (DMIIC)

FRANCE

NOUVELLE AQUITAINE
LIMOGES

Ongoing trial
AmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Recruiting trial
Ongoing trial
SCLERADEC III : SCLERoderma and Adipose-DErived Stroma Cells (Phase II)
CHU de Marseille - Hôpital Nord
Service de Médecine Interne

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
An open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis -DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberINTENT Study: Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter study - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
TOFFIFE: Tocilizumab for the Treatment of Familial Mediterranean Fever - A randomized, doubleblind, phase II proof of concept study
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Berlin
BERLIN

Recruiting trial
Ongoing trial
CONSIDER: Canakinumab for Treatment of Adult Onset Still's Disease to Achieve Reduction of Arthritic Manifestation - DE
Charité - Universitätsmedizin Berlin (CCM)
Autoinflammation Reference Center Charité (ARC˛)

HUNGARY

Közép-Magyarország
BUDAPEST

ITALY

LAZIO
ROMA

Ongoing trial
Efficacy of monoclonal anti CD 20 antibodies in steroid and cyclosporin dependent nephrotic syndrome in children - IT
IRCCS Ospedale Pediatrico Bambino Gesů - SEDE SAN PAOLO
Laboratorio di Nefrologia - Divisione di Nefrologia e Dialisi

ITALY

LIGURIA
GENOVA

Ongoing trial
Five-year actively controlled clinical trial in new onset juvenile dermatomyositis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

ITALY

TOSCANA
FIRENZE

Ongoing trial
Randomized Controlled Trial for Testing the Efficacy of Well-Being Therapy in Patients With Systemic Sclerosis
Universitŕ degli studi di Firenze
Dipartimento di Scienze della Salute

NETHERLANDS

Utrecht
UTRECHT

UNITED KINGDOM

Greater London
LONDON

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIUM

OOST-VLAANDEREN
GENT

Recruiting trial
Ongoing trial
NOVESA studie: GLPG1690 in de behandeling van vroegtijdige diffuse systeemsclerose - BE
Ghent University Hospital - UZ Gent
Department of Rheumatology

FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Ongoing trial
METOGiA: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de médecine interne et immunologie clinique

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
Funded by an IRDiRC memberMSC-LES: Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord
AP-HP.Centre - Université de Paris - Hôpital Cochin
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
CHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
AP-HP.Centre - Université de Paris - Hôpital Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCE

ILE-DE-FRANCE
PARIS

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
ISLAND-SLE: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus - DE
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Bayern
ERLANGEN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

GERMANY

Berlin
BERLIN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

GERMANY

Hamburg
HAMBURG

GERMANY

Hessen
FRANKFURT AM MAIN

GERMANY

Schleswig-Holstein
KIEL

ITALY

PUGLIA
BARI

Recruiting trial
Ongoing trial
Combined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unitŕ di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

NETHERLANDS

Groningen
GRONINGEN

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Recruiting trial
Ongoing trial
Rituximab and Belimumab Combination Therapy in PR3 COMBIVAS
Addenbrooke's Hospital
Addenbrookes Hospital

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Ongoing trial
Funded by an IRDiRC memberBiologics in refractory vasculitis
University of Cambridge
Department of Medicine

UNITED KINGDOM

Derbyshire
CHESTERFIELD

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US